Clinical Trial: Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer

U.S., June 7 -- ClinicalTrials.gov registry received information related to the study (NCT07009457) titled 'Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer' on May 29.

Brief Summary: This study is a multicenter, open label phase I clinical trial aimed at evaluating the pharmacokinetics, tolerability, safety and immunogenicity of SHR-1316 (sc) subcutaneous administration combined with carboplatin and etoposide as first-line treatment for extensive stage small cell lung cancer, and to observe the initial anti-tumor efficacy.

Study Start Date: June, 2025

Study Type: INTERVENTIONAL

Condition: Widespread Small Cell Lung Cancer

Intervention: ...